EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT. Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.
Location: United States, Connecticut, Branford
Employees: 11-50
Founded date: 2020
Investors 2
| Date | Name | Website |
| - | Takeda Ven... | takeda.com |
| - | Solasta Ve... | solasta-ve... |
Mentions in press and media 2
| Date | Title | Description |
| 31.10.2024 | AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics | - |
| - | EvolveImmune Therapeutics | “At EvolveImmune, we harness our “Immunology First” approach to create first-in-category cancer medicines to transform the lives of patients.” |